Jiangsu Yangnong Chemical Co., Ltd. (SHA:600486)
China · Delayed Price · Currency is CNY 72.34
-1.68 (-2.27%)
Apr 30, 2026, 3:00 PM CST
Jiangsu Yangnong Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 11,888 | 11,661 | 10,270 | 11,285 | 15,555 | 11,710 |
Other Revenue | 209.04 | 209.04 | 165.14 | 192.43 | 255.55 | 131.27 |
| 12,097 | 11,870 | 10,435 | 11,478 | 15,811 | 11,841 | |
Revenue Growth (YoY) | 15.21% | 13.76% | -9.09% | -27.41% | 33.52% | 20.45% |
Cost of Revenue | 9,534 | 9,265 | 8,037 | 8,564 | 11,769 | 9,117 |
Gross Profit | 2,562 | 2,605 | 2,398 | 2,914 | 4,042 | 2,725 |
Selling, General & Admin | 661.76 | 673.58 | 695.31 | 744.68 | 1,180 | 850.24 |
Research & Development | 394.11 | 392.87 | 358.16 | 418.03 | 498.02 | 373.53 |
Other Operating Expenses | 26.12 | 22.55 | -5.83 | 47.41 | 43.84 | 28.59 |
Operating Expenses | 1,128 | 1,135 | 1,035 | 1,121 | 1,821 | 1,288 |
Operating Income | 1,435 | 1,470 | 1,363 | 1,793 | 2,220 | 1,437 |
Interest Expense | -41.39 | -41.39 | -64.61 | -45.83 | -59.44 | -42.56 |
Interest & Investment Income | 126.37 | 126.37 | 124.48 | 95.29 | 29.53 | 48.92 |
Currency Exchange Gain (Loss) | -27.36 | -27.36 | 11.13 | 12.76 | 279.94 | -59.29 |
Other Non Operating Income (Expenses) | 12.47 | -3.17 | -7.48 | -3.46 | -4.08 | -6.28 |
EBT Excluding Unusual Items | 1,505 | 1,525 | 1,427 | 1,851 | 2,466 | 1,377 |
Gain (Loss) on Sale of Investments | -0.79 | 0.73 | -3.19 | -11.67 | -186.94 | 42.82 |
Gain (Loss) on Sale of Assets | 0.1 | 0.1 | 15.85 | 5.06 | 1.9 | 0.53 |
Asset Writedown | -30.27 | -26.39 | -60.16 | -6.57 | -171.73 | -0.95 |
Other Unusual Items | 11.91 | 11.91 | 26.68 | 27.87 | 25.77 | 20.68 |
Pretax Income | 1,486 | 1,511 | 1,406 | 1,866 | 2,135 | 1,440 |
Income Tax Expense | 227.04 | 224.72 | 203.17 | 299.98 | 339.69 | 217.4 |
Earnings From Continuing Operations | 1,259 | 1,287 | 1,203 | 1,566 | 1,796 | 1,223 |
Minority Interest in Earnings | -0.53 | -0.63 | -0.88 | -1.15 | -1.44 | -0.99 |
Net Income | 1,258 | 1,286 | 1,202 | 1,565 | 1,794 | 1,222 |
Net Income to Common | 1,258 | 1,286 | 1,202 | 1,565 | 1,794 | 1,222 |
Net Income Growth | 4.15% | 6.98% | -23.19% | -12.77% | 46.82% | 1.02% |
Shares Outstanding (Basic) | 403 | 403 | 404 | 405 | 403 | 403 |
Shares Outstanding (Diluted) | 403 | 404 | 404 | 405 | 403 | 403 |
Shares Change (YoY) | -0.23% | -0.01% | -0.24% | 0.42% | 0.00% | 0.02% |
EPS (Basic) | 3.12 | 3.19 | 2.98 | 3.87 | 4.45 | 3.03 |
EPS (Diluted) | 3.12 | 3.19 | 2.98 | 3.87 | 4.45 | 3.03 |
EPS Growth | 4.39% | 6.98% | -23.01% | -13.14% | 46.81% | 1.00% |
Free Cash Flow | 1,482 | 1,255 | 320.12 | 876.64 | 956.94 | 122.35 |
Free Cash Flow Per Share | 3.68 | 3.11 | 0.79 | 2.17 | 2.38 | 0.30 |
Dividend Per Share | 0.954 | 0.954 | 0.680 | 0.880 | 1.000 | 0.500 |
Dividend Growth | 40.29% | 40.29% | -22.73% | -12.00% | 100.00% | - |
Gross Margin | 21.18% | 21.95% | 22.98% | 25.39% | 25.56% | 23.01% |
Operating Margin | 11.86% | 12.39% | 13.07% | 15.62% | 14.04% | 12.13% |
Profit Margin | 10.40% | 10.83% | 11.52% | 13.63% | 11.35% | 10.32% |
Free Cash Flow Margin | 12.25% | 10.58% | 3.07% | 7.64% | 6.05% | 1.03% |
EBITDA | 2,260 | 2,272 | 2,069 | 2,533 | 2,862 | 2,013 |
EBITDA Margin | 18.69% | 19.14% | 19.83% | 22.07% | 18.10% | 17.00% |
D&A For EBITDA | 825.84 | 801.83 | 705.79 | 740.29 | 641.76 | 576.62 |
EBIT | 1,435 | 1,470 | 1,363 | 1,793 | 2,220 | 1,437 |
EBIT Margin | 11.86% | 12.39% | 13.07% | 15.62% | 14.04% | 12.13% |
Effective Tax Rate | 15.28% | 14.87% | 14.45% | 16.07% | 15.91% | 15.09% |
Revenue as Reported | 11,870 | 11,870 | 10,435 | 11,478 | 15,811 | 11,841 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.